Neuropeptide Q as modulator of GPCR GALR2 and uses thereof
US-9057726-B2 · Jun 16, 2015 · US
This page is not indexed by search engines while we improve data quality.
Actelion Pharmaceuticals Ltd — Physics
Actelion Pharmaceuticals Ltd holds 1 patent in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Actelion Pharmaceuticals Ltd |
| Technology | Physics |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2015 |
| Last year | 2015 |
Representative patents
Notable publications linking Actelion Pharmaceuticals Ltd to Physics.
Neuropeptide Q as modulator of GPCR GALR2 and uses thereof
US-9057726-B2 · Jun 16, 2015 · US
Neuropeptide Q as modulator of GPCR GALR2 and uses thereof
US-9057726-B2 · Jun 16, 2015 · US
Recent filings
Latest patents from Actelion Pharmaceuticals Ltd in Physics.
Neuropeptide Q as modulator of GPCR GALR2 and uses thereof
US-9057726-B2 · Jun 16, 2015 · US
Neuropeptide Q as modulator of GPCR GALR2 and uses thereof
US-9057726-B2 · Jun 16, 2015 · US
Neuropeptide Q as modulator of GPCR GALR2 and uses thereof
US-9057726-B2 · Jun 16, 2015 · US
Related pages
Navigate to parent entity pages.